Clinical Trials Logo

Nystagmus, Acquired clinical trials

View clinical trials related to Nystagmus, Acquired.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00661440 Completed - Nystagmus, Acquired Clinical Trials

Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus

Start date: May 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN) in comparison to placebo. In addition, a subgroup of multiple sclerosis (MS) patients suffering from acquired nystagmus will be included; this subgroup will be analyzed in an exploratory manner only.